← Leaderboards
Joerg C Gerlach
University Of Pittsburgh At Pittsburgh
$1,774,629
Attributed
$3,814,363
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $505.4K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,814,363 · 4
By mechanism
R01$2,992,500 · 2
R21$821,863 · 2
Top collaborators
- Ian Nettleship4 shared
- Eva Schmelzer4 shared
- Pablo G Sanchez3 shared
- Yoram Vodovotz3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Gregory F Cooper$10,856,842
- Ivet Bahar$22,253,131
- David Alan Vorp$12,987,916
- Steven A Webber$15,503,800
- Jeremy M Berg$3,800,513
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoCellsHepatocyteOrganBioreactorsTissuesIn VitroPerfusionPlayTechnologyIn Vitro ModelInflammationInflammatoryBiomedical EngineeringRegulationBaseRattusClinically SignificantCytokineExperimental ModelsHepaticInjuryReactionResponse
Grant awards (12)
Incorporating hepatic cell function into lung ex vivo lung perfusion for transplant preservatio$167,908
R21 · FY2024 · HL
Incorporating hepatic cell function into lung ex vivo lung perfusion for transplant preservation$30,842
R21 · FY2024 · HL
Incorporating hepatic cell function into lung ex vivo lung perfusion for transplant preservation$238,500
R21 · FY2023 · HL
A Biohybrid Device for Regulating Inflammation in Sepsis$350,063
R01 · FY2017 · GM
A Biohybrid Device for Regulating Inflammation in Sepsis$346,781
R01 · FY2016 · GM
A Biohybrid Device for Regulating Inflammation in Sepsis$346,500
R01 · FY2015 · GM
Innovative In Vivo-like Model for Vascular Tissue Engineering$482,562
R01 · FY2014 · HL · contact PI
Innovative In Vivo-like Model for Vascular Tissue Engineering$468,775
R01 · FY2013 · HL · contact PI
Innovative In Vivo-like Model for Vascular Tissue Engineering$492,410
R01 · FY2012 · HL · contact PI
Innovative In Vivo-like Model for Vascular Tissue Engineering$505,409
R01 · FY2011 · HL · contact PI
3D Culture of mES Cells in Four-Compartment Bioreactors$181,263
R21 · FY2006 · EB · contact PI
3D Culture of mES Cells in Four-Compartment Bioreactors$203,350
R21 · FY2005 · EB